The FDA sent a warning across the bow of all CBD providers and retailers to not market their products as medicinal in nature and to remove those claims from websites and marketing materials. Leading retail trail blazer Curaleaf ( https://www.curaleaf.com/) received official notification from the FDA that some of the benefits they are claiming could cause consumers to delay traditional cancer treatments or other disease related treatments in lieu of trying CBD as an alternative medicine. Curaleaf says it will work with regulators as they begin defining FDA regulations on how CBD can be marketed and infused into additional products.
We have never made any medical claims about the products we sell at http://texastretailcbd.com. Our customers already know the benefits and continue to use this revolutionary product.